Jiangsu Hengrui Medicine Statistics

Total Valuation

HKG:1276 has a market cap or net worth of HKD 395.05 billion. The enterprise value is 369.43 billion.

Market Cap	395.05B
Enterprise Value	369.43B

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	258.20M
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-1.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.69B

Valuation Ratios

The trailing PE ratio is 53.86 and the forward PE ratio is 46.42.

PE Ratio	53.86
Forward PE	46.42
PS Ratio	12.62
PB Ratio	7.75
P/TBV Ratio	8.08
P/FCF Ratio	79.87
P/OCF Ratio	54.80
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 43.44, with an EV/FCF ratio of 74.69.

EV / Earnings	50.36
EV / Sales	11.62
EV / EBITDA	43.44
EV / EBIT	48.29
EV / FCF	74.69

Financial Position

The company has a current ratio of 10.70, with a Debt / Equity ratio of 0.00.

Current Ratio	10.70
Quick Ratio	9.38
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	426.12

Financial Efficiency

Return on equity (ROE) is 15.22% and return on invested capital (ROIC) is 9.74%.

Return on Equity (ROE)	15.22%
Return on Assets (ROA)	8.99%
Return on Invested Capital (ROIC)	9.74%
Return on Capital Employed (ROCE)	14.65%
Revenue Per Employee	1.55M
Profits Per Employee	362,457
Employee Count	20,238
Asset Turnover	0.60
Inventory Turnover	1.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	19,957,419

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1276 had revenue of HKD 31.30 billion and earned 7.34 billion in profits. Earnings per share was 1.17.

Revenue	31.30B
Gross Profit	27.00B
Operating Income	7.53B
Pretax Income	8.30B
Net Income	7.34B
EBITDA	8.31B
EBIT	7.53B
Earnings Per Share (EPS)	1.17

Full Income Statement

Balance Sheet

The company has 25.94 billion in cash and 116.51 million in debt, giving a net cash position of 25.83 billion.

Cash & Cash Equivalents	25.94B
Total Debt	116.51M
Net Cash	25.83B
Net Cash Per Share	n/a
Equity (Book Value)	50.98B
Book Value Per Share	8.06
Working Capital	34.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.21 billion and capital expenditures -2.26 billion, giving a free cash flow of 4.95 billion.

Operating Cash Flow	7.21B
Capital Expenditures	-2.26B
Free Cash Flow	4.95B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 86.28%, with operating and profit margins of 24.06% and 23.44%.

Gross Margin	86.28%
Operating Margin	24.06%
Pretax Margin	26.52%
Profit Margin	23.44%
EBITDA Margin	26.57%
EBIT Margin	24.06%
FCF Margin	15.80%

Dividends & Yields

HKG:1276 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	18.63%
Buyback Yield	0.91%
Shareholder Yield	n/a
Earnings Yield	1.86%
FCF Yield	1.25%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1276 has an Altman Z-Score of 48.78.

Altman Z-Score	48.78
Piotroski F-Score	n/a